Inhibition of SHH signaling with cyclopamine resulted in developmental defects in the midbrain of zebrafish embryos at 24 hpf. (A–D) Zebrafish embryos at 24 hpf which were treated 0.2% and 0.6% EtOH from 4 hpf. 0.6% EtOH-exposed embryos showed similar phenotypes of midbrain and MHB in comparison to those of 0.2% EtOH-exposed embryos. (E and F) Cyclopamine-treated embryos (20 μM) showed reduction in width of the midbrain and dorsally shrunken midbrain in comparison to those of EtOH controls. (G and H) 60 μM cyclopamine-treated embryos exhibited severe defects in the midbrain. (I–L) Spatiotemporal expression patterns of otx2b in the midbrain of cyclopamine-treated embryos at 24 hpf. CCP, cyclopamine. (A–L) Scale bars: 50 μm.
|